FDA Inspection 1086637 — BodyBio Inc.
The FDA completed an inspection of BodyBio Inc. on April 18, 2019 in Millville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 3 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 18, 2019
- Fiscal Year
- 2019
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Millville, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15545 | 21 CFR 111.260(e) | Batch record - component; identity, weight |
| 15762 | 21 CFR 111.205(a) | Master manufacturing record - each batch |
| 15864 | 21 CFR 111.75(a)(2)(ii)(C) | Documentation - qualify supplier |